Cliquer ici pour toutes les publications du CNR-MyRMA en 2012 / click here
1368488
JT79M536
items
1
art-libraries-society-of-north-america-arlisna-reviews
0
default
asc
239
https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-fda89abccd99dd78df946c6a81ebeb4e%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22JT79M536%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pantel%20et%20al.%22%2C%22parsedDate%22%3A%222012-04%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%26%23x201C%3BExtending%20the%20Definition%20of%20the%20GyrB%20Quinolone%20Resistance-Determining%20Region%20in%20Mycobacterium%20Tuberculosis%20DNA%20Gyrase%20for%20Assessing%20Fluoroquinolone%20Resistance%20in%20M.%20Tuberculosis%26%23x201D%3B%20by%20Alix%20Pantel%20et%20al.%20%3Ci%3EAntimicrobial%20Agents%20and%20Chemotherapy%3C%5C%2Fi%3E.%2056%2C%20no.%204%20%28April%202012%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.06272-11%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.06272-11%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Extending%20the%20Definition%20of%20the%20GyrB%20Quinolone%20Resistance-Determining%20Region%20in%20Mycobacterium%20tuberculosis%20DNA%20Gyrase%20for%20Assessing%20Fluoroquinolone%20Resistance%20in%20M.%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alix%22%2C%22lastName%22%3A%22Pantel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Petrella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvaine%22%2C%22lastName%22%3A%22Bastian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudine%22%2C%22lastName%22%3A%22Mayer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22Fluoroquinolone%20%28FQ%29%20resistance%20is%20emerging%20in%20Mycobacterium%20tuberculosis.%20The%20main%20mechanism%20of%20FQ%20resistance%20is%20amino%20acid%20substitution%20within%20the%20quinolone%20resistance-determining%20region%20%28QRDR%29%20of%20the%20GyrA%20subunit%20of%20DNA%20gyrase%2C%20the%20sole%20FQ%20target%20in%20M.%20tuberculosis.%20However%2C%20substitutions%20in%20GyrB%20whose%20implication%20in%20FQ%20resistance%20is%20unknown%20are%20increasingly%20being%20reported.%20The%20present%20study%20clarified%20the%20role%20of%20four%20GyrB%20substitutions%20identified%20in%20M.%20tuberculosis%20clinical%20strains%2C%20two%20located%20in%20the%20QRDR%20%28D500A%20and%20N538T%29%20and%20two%20outside%20the%20QRDR%20%28T539P%20and%20E540V%29%2C%20in%20FQ%20resistance.%20We%20measured%20FQ%20MICs%20and%20also%20DNA%20gyrase%20inhibition%20by%20FQs%20in%20order%20to%20unequivocally%20clarify%20the%20role%20of%20these%20mutations%20in%20FQ%20resistance.%20Wild-type%20GyrA%2C%20wild-type%20GyrB%2C%20and%20mutant%20GyrB%20subunits%20produced%20from%20engineered%20gyrB%20alleles%20by%20mutagenesis%20were%20overexpressed%20in%20Escherichia%20coli%2C%20purified%20to%20homogeneity%2C%20and%20used%20to%20reconstitute%20highly%20active%20gyrase%20complexes.%20MICs%20and%20DNA%20gyrase%20inhibition%20were%20determined%20for%20moxifloxacin%2C%20gatifloxacin%2C%20ofloxacin%2C%20levofloxacin%2C%20and%20enoxacin.%20All%20these%20substitutions%20are%20clearly%20implicated%20in%20FQ%20resistance%2C%20underlining%20the%20presence%20of%20a%20hot%20spot%20region%20housing%20most%20of%20the%20GyrB%20substitutions%20implicated%20in%20FQ%20resistance%20%28residues%20NTE%2C%20538%20to%20540%29.%20These%20findings%20help%20us%20to%20refine%20the%20definition%20of%20GyrB%20QRDR%2C%20which%20is%20extended%20to%20positions%20500%20to%20540.%22%2C%22date%22%3A%222012-4%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.06272-11%22%2C%22ISSN%22%3A%220066-4804%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC3318379%5C%2F%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222015-07-20T16%3A54%3A20Z%22%7D%7D%5D%7D
“Extending the Definition of the GyrB Quinolone Resistance-Determining Region in Mycobacterium Tuberculosis DNA Gyrase for Assessing Fluoroquinolone Resistance in M. Tuberculosis” by Alix Pantel et al. Antimicrobial Agents and Chemotherapy. 56, no. 4 (April 2012). https://doi.org/10.1128/AAC.06272-11.